FDA Inspection 1017549 — AstraZeneca UK Ltd.
The FDA completed an inspection of AstraZeneca UK Ltd. on Apr 13, 2017 in Macclesfield. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 13, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Macclesfield (United Kingdom)